1. Home
  2. SAVA vs SKLZ Comparison

SAVA vs SKLZ Comparison

Compare SAVA & SKLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAVA
  • SKLZ
  • Stock Information
  • Founded
  • SAVA 1998
  • SKLZ 2012
  • Country
  • SAVA United States
  • SKLZ United States
  • Employees
  • SAVA N/A
  • SKLZ N/A
  • Industry
  • SAVA Biotechnology: Pharmaceutical Preparations
  • SKLZ EDP Services
  • Sector
  • SAVA Health Care
  • SKLZ Technology
  • Exchange
  • SAVA Nasdaq
  • SKLZ Nasdaq
  • Market Cap
  • SAVA 70.5M
  • SKLZ 80.3M
  • IPO Year
  • SAVA N/A
  • SKLZ N/A
  • Fundamental
  • Price
  • SAVA $1.99
  • SKLZ $7.02
  • Analyst Decision
  • SAVA Buy
  • SKLZ Buy
  • Analyst Count
  • SAVA 3
  • SKLZ 2
  • Target Price
  • SAVA $54.50
  • SKLZ $10.75
  • AVG Volume (30 Days)
  • SAVA 1.1M
  • SKLZ 52.4K
  • Earning Date
  • SAVA 08-07-2025
  • SKLZ 07-31-2025
  • Dividend Yield
  • SAVA N/A
  • SKLZ N/A
  • EPS Growth
  • SAVA N/A
  • SKLZ N/A
  • EPS
  • SAVA N/A
  • SKLZ N/A
  • Revenue
  • SAVA N/A
  • SKLZ $92,644,000.00
  • Revenue This Year
  • SAVA N/A
  • SKLZ $0.20
  • Revenue Next Year
  • SAVA N/A
  • SKLZ $14.10
  • P/E Ratio
  • SAVA N/A
  • SKLZ N/A
  • Revenue Growth
  • SAVA N/A
  • SKLZ N/A
  • 52 Week Low
  • SAVA $1.15
  • SKLZ $3.54
  • 52 Week High
  • SAVA $42.20
  • SKLZ $7.18
  • Technical
  • Relative Strength Index (RSI)
  • SAVA 51.90
  • SKLZ 68.84
  • Support Level
  • SAVA $1.76
  • SKLZ $6.59
  • Resistance Level
  • SAVA $2.17
  • SKLZ $7.11
  • Average True Range (ATR)
  • SAVA 0.10
  • SKLZ 0.22
  • MACD
  • SAVA -0.02
  • SKLZ 0.03
  • Stochastic Oscillator
  • SAVA 55.95
  • SKLZ 91.42

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About SKLZ Skillz Inc.

Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.

Share on Social Networks: